Individuals from 10 of age, with a medical condition included in (excluding the severely immunocompromised4) do not require PCV13. Severely immunocompromised4 individuals should be offered a single dose of PCV13 irrespective of any routine childhood vaccinations they have already received. Pneumococcal polysaccharide vaccine (PPV23) Additionally, all individuals with a medical condition included in should receive a dose of PPV23 after their second birthday (see PPV PGD). Individuals eligible for both PCV13 and PPV23 should have the PCV13 dose first followed by PPV23 at least 2 months later. Duration of treatment Single 0.5ml dose Quantity to be supplied / Single 0.5ml dose per administration. administered Continued over page PCV13 for additional doses for at risk groups is not centrally procured and these should be ordered from the manufacturer. Supplies Details are given in the Green Book . Centrally purchased vaccines for the national childhood routine PCV13 immunisation programme for the NHS can only be ordered via ImmForm. Vaccines for use for the national childhood routine immunisation programme are provided free of charge. Protocols for the ordering, storage and handling of vaccines should be followed to prevent vaccine wastage (see and Book ). Storage Store at +2°C to +8°C. Store in original packaging in order to protect from light. Do not freeze. Note: Prevenar 13 is stable at temperatures up to 25°C for four days. At the end of this period Prevenar 13 should be used or discarded. These data are intended to guide health care professionals in case of inadvertent temporary temperature excursions only. Equipment used for immunisation, including used ampoules, or discharged vaccines in a syringe or applicator, should be disposed of Disposal at the end of a session by sealing in a UN-approved box, according to local authority regulations and ‘sharps’ guidance in the : Safe management of healthcare waste (Department of Health, 2013). Drug interactions Immunological response may be diminished in those receiving immunosuppressive treatment. May be at the same time as other vaccines. A detailed list of interactions is available in the SPC, which is available from the electronic Medicines Compendium website:
Individuals from 10 of age, with a medical condition included in (excluding the severely immunocompromised4) do not require PCV13. Severely immunocompromised4 individuals should be offered a single dose of PCV13 irrespective of any routine childhood vaccinations they have already received. Pneumococcal polysaccharide vaccine (PPV23) Additionally, all individuals with a medical condition included in should receive a dose of PPV23 after their second birthday (see PPV PGD). Individuals eligible for both PCV13 and PPV23 should have the PCV13 dose first followed by PPV23 at least 2 months later. Duration of treatment Single 0.5ml dose Quantity to be supplied / administered Single 0.5ml dose per administration. Continued over page Supplies PCV13 for additional doses for at risk groups is not centrally procured and these should be ordered from the manufacturer. Details are given in the Green Book . Centrally purchased vaccines for the national childhood routine PCV13 immunisation programme for the NHS can only be ordered via ImmForm. Vaccines for use for the national childhood routine immunisation programme are provided free of charge. Protocols for the ordering, storage and handling of vaccines should be followed to prevent vaccine wastage (see and Book ). Storage Store at +2°C to +8°C. Store in original packaging in order to protect from light. Do not freeze. Note: Prevenar 13 is stable at temperatures up to 25°C for four days. At the end of this period Prevenar 13 should be used or discarded. These data are intended to guide health care professionals in case of inadvertent temporary temperature excursions only. Disposal Equipment used for immunisation, including used ampoules, or discharged vaccines in a syringe or applicator, should be disposed of at the end of a session by sealing in a UN-approved ‘sharps’ box, according to local authority regulations and guidance in the : Safe management of healthcare waste (Department of Health, 2013). Drug interactions Immunological response may be diminished in those receiving immunosuppressive treatment. May be at the same time as other vaccines. A detailed list of interactions is available in the SPC, which is available from the electronic Medicines Compendium website:
20170510PHEPGDPCVRiskGroupsV02.00.docx